Stanford study identifies six depression biotypes for personalized treatment

FHS
June 17, 2024
1:51 pm

In the not-too-distant future, a screening assessment for depression could include a quick brain scan to identify the best treatment.

Grifols gears up for FDA approval of fibrinogen replacement therapy

Share this article Grifols plans to file for regulatory approval for the AdFIrst (BT524) in both Europe and the US in Q4 of this year.

February 14, 2024

Pharmalittle: Nearly half of U.S. adults would spend $100 a month for weight loss drugs; Pfizer scraps an obesity pill

Good morning, everyone. and welcome to another working week. We hope the weekend respite was restful and invigorating because now that familiar routine of online

June 26, 2023

Do probiotics supplements really make a difference during antibiotic treatment? Probably not, says research

Researchers evaluated previous work conducting controlled trials of patients undergoing antibiotic therapy.

July 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.